Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Jhawer M, Rosen L, Dancey J, Hochster H, Hamburg S, Tempero M, Clendeninn N, Mani S

Publication

Investigational new drugs

Publication ID (Profile URL)

https://researcherprofiles.org/profile/1450662

Publication Year

2006

PubMed ID

16957834

Publication Title

Jhawer M, Rosen L, Dancey J, Hochster H, Hamburg S, Tempero M, Clendeninn N, Mani S. Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma. Invest New Drugs. 2007 Feb; 25(1):85-94.